Mark Steven CohenView profile
Professor
Mark Steven Cohen is the Dean and Senior Vice President & Chief Academic Officer at Carle Illinois College of Medicine. He holds the title of Professor in multiple departments including Biomedical and Translational Sciences, Clinical Sciences, Bioengineering, and affiliated institutes like Beckman Institute for Advanced Science and Technology. His research focuses on cancer pharmacology, drug repurposing (e.g., sulfasalazine for adrenocortical carcinomas), Hsp90 inhibitors for melanoma treatment, and medical imaging technologies integrated with mixed reality for clinical training. Recent work emphasizes overcoming drug resistance in melanoma via C-terminal Hsp90 inhibitors and advancing healthcare innovation through mixed reality applications. Cohen has contributed to over 121 scholarly publications and media engagements, including commentaries on AI’s impact on healthcare and the LCME accreditation of Carle Illinois College of Medicine. His interdisciplinary collaborations span bioengineering, genomic biology, and clinical sciences, reflecting his role as a founder professor in bioengineering and his leadership in translational research initiatives.








